Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FV693
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,879
Award facts
- Contract value 100% obligated
- $16,879.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,879.10 to AmerSourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-unit supply) on January 21, 2026, with completion expected by January 22, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's headquarters in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing one of many pharmaceutical products supplied through the contractor's existing contract vehicle with DLA.
This delivery order was issued under AmerSourceBergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical supply agreement running through December 2031. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerSourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting military healthcare systems and other federal agencies. The company's consistent receipt of competitive awards across multiple therapeutic domains demonstrates its established capability to meet federal pharmaceutical procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26FV693?
SPE2DR26FV693 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV693 worth?
The government has obligated $16,879 on SPE2DR26FV693.
Is contract SPE2DR26FV693 an order under another contract?
Yes. SPE2DR26FV693 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV693 competed?
The extent of competition for SPE2DR26FV693 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award